Amag Pharmaceuticals Inc Net Income per Employee (AMAG), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Amag Pharmaceuticals inc   (NASDAQ: AMAG)
 

Amag Pharmaceuticals Inc Net Income per Employee

AMAG's Quarterly Results, Trends, Rankings, Statistics
Amag Pharmaceuticals Inc recorded a cumulative net loss of $-181 million during 12 month ending in the third quarter 2020.
The Healthcare sector has seen employees of 130 other companies achieving higher income per employee. While Amag Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 3392.


What is Income per Employee Ratio?






AMAG Net Income per Employee (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -277,718 -343,823 -529,957 -717,625 -444,712
AMAG's Total Ranking # 3392 # 0 # 0 # 0 # 0
Seq. Net Income Change 11994.38 % - - - -


AMAG Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 131
Healthcare Sector # 414
Overall Market # 3392

Net Income per Employee Statistics
High Average Low
$ 293,274 $ -128,759 $ -719,478
(June 30. 2015)   (Dec 31 2019)







Companies with similar Income per Employee for 12 month ending Sep 30 2020, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2020Number of Employees Sep 30 2020


Date modified: 2026-09-08T15:10:04+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.